Pasithea Therapeutics KTTAW Peer Comparison

NASDAQ KTTAW
$0.00 0.00 (-36.36%)
As of: Sep 9, 2026 · 3:56 PM EDT
Peer Comparison

300 Comparable Companies

Industry Biotechnology

The table below compares all 300 Biotechnology companies on 8 financial metrics.

Download Data
# Ticker Company match industry_code industry_group industry_group_code Market Capitalization P/E P/S Enterprise Value
1 AMGN Amgen Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 211.73 Bn 24.22 5.56 197.74 Bn
2 GILD Gilead Sciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 180.92 Bn -62.49 5.94 177.74 Bn
3 VRTX Vertex Pharmaceuticals Inc / Ma primary H-02 Pharmaceuticals and Biotechnology HG-01 132.16 Bn 30.00 10.50 124.30 Bn
4 REGN Regeneron Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 82.89 Bn 19.15 5.34 74.90 Bn
5 ARGX Argenx Se primary H-02 Pharmaceuticals and Biotechnology HG-01 61.41 Bn 35.80 11.75 56.23 Bn
6 MRNA Moderna, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 53.99 Bn -17.13 24.23 48.85 Bn
7 ALNY Alnylam Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 34.48 Bn 44.51 7.18 31.18 Bn
8 BIIB Biogen Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 31.15 Bn 37.32 3.11 29.86 Bn
9 ROIV Roivant Sciences Ltd. primary H-02 Pharmaceuticals and Biotechnology HG-01 30.05 Bn -20.25 2,751.33 30.05 Bn
10 INSM INSMED Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 27.99 Bn -31.97 24.60 26.83 Bn
11 BNTX BioNTech SE primary H-02 Pharmaceuticals and Biotechnology HG-01 23.72 Bn -13.92 7.67 10.06 Bn
12 MDGL Madrigal Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 15.87 Bn -49.74 12.36 15.03 Bn
13 ASND Ascendis Pharma A/S primary H-02 Pharmaceuticals and Biotechnology HG-01 15.87 Bn 18.30 11.19 14.92 Bn
14 BBIO BridgeBio Pharma, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 14.90 Bn -21.53 20.89 14.18 Bn
15 SMMT Summit Therapeutics Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 13.63 Bn — — 12.94 Bn
16 HALO Halozyme Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 12.58 Bn 30.43 7.56 12.35 Bn
17 BMRN Biomarin Pharmaceutical Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 12.45 Bn 170.57 3.65 11.57 Bn
18 ARWR Arrowhead Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 11.85 Bn -43.53 17.69 10.24 Bn
19 AAVXF Abivax S.A. primary H-02 Pharmaceuticals and Biotechnology HG-01 10.92 Bn -25.97 — 10.92 Bn
20 APGE Apogee Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 10.18 Bn -34.62 — 9.20 Bn
21 PRAX Praxis Precision Medicines, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 10.05 Bn -26.35 — 9.29 Bn
22 PTGX Protagonist Therapeutics, Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 9.56 Bn 86.62 33.92 9.56 Bn
23 IONS Ionis Pharmaceuticals Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 9.24 Bn -43.52 10.57 7.18 Bn
24 PCVX Vaxcyte, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 8.59 Bn -8.13 — 8.59 Bn
25 IBRX ImmunityBio, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 8.47 Bn -8.54 51.11 8.12 Bn
26 IMVT Immunovant, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 7.97 Bn -14.81 — 7.97 Bn
27 TGTX Tg Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 7.77 Bn 17.59 9.72 7.09 Bn
28 GIFLF Grifols SA primary H-02 Pharmaceuticals and Biotechnology HG-01 7.54 Bn 29.70 0.46 9.09 Bn
29 SYRE Spyre Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 7.38 Bn -41.27 — 7.38 Bn
30 SRRK Scholar Rock Holding Corp primary H-02 Pharmaceuticals and Biotechnology HG-01 7.14 Bn -17.69 — 7.14 Bn
31 RYTM Rhythm Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 6.93 Bn -32.98 28.90 6.60 Bn
32 CGON CG Oncology, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 6.36 Bn -28.39 1,021.85 6.36 Bn
33 BLRX BioLineRx Ltd. primary H-02 Pharmaceuticals and Biotechnology HG-01 6.31 Bn -704.68 4,533.84 6.31 Bn
34 MIRM Mirum Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 6.25 Bn -7.27 10.12 5.82 Bn
35 KNSA Kiniksa Pharmaceuticals International, plc primary H-02 Pharmaceuticals and Biotechnology HG-01 6.09 Bn 75.51 7.24 5.56 Bn
36 XENE Xenon Pharmaceuticals Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 5.87 Bn -16.20 — 5.87 Bn
37 COGT Cogent Biosciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 5.84 Bn -15.79 — 5.84 Bn
38 DBVT DBV Technologies S.A. primary H-02 Pharmaceuticals and Biotechnology HG-01 5.83 Bn -33.11 1,160.93 5.65 Bn
39 LGND Ligand Pharmaceuticals Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 5.78 Bn 29.31 19.90 4.42 Bn
40 ORKA Oruka Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 5.74 Bn — — 4.01 Bn
41 PTCT Ptc Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 5.62 Bn 14.70 5.57 3.39 Bn
42 CELC Celcuity Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 4.98 Bn -22.73 — 4.98 Bn
43 ERAS Erasca, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 4.89 Bn -17.03 — 4.89 Bn
44 DNLI Denali Therapeutics Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 4.06 Bn -7.94 1,126.80 4.06 Bn
45 DNTH Dianthus Therapeutics, Inc. /DE/ primary H-02 Pharmaceuticals and Biotechnology HG-01 4.05 Bn — — 3.64 Bn
46 TLPPF Telix Pharmaceuticals Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 3.89 Bn -521.64 4.64 3.59 Bn
47 VKTX Viking Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 3.83 Bn -7.15 — 3.83 Bn
48 RLAY Relay Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 3.80 Bn -13.27 366.70 3.80 Bn
49 AMLX Amylyx Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 3.60 Bn -29.59 — 3.60 Bn
50 RCUS Arcus Biosciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 3.59 Bn -7.79 30.64 2.88 Bn
51 TNGX Tango Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 3.57 Bn -34.90 66.37 2.56 Bn
52 IDYA IDEAYA Biosciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 3.54 Bn -16.07 15.11 2.71 Bn
53 ABCL AbCellera Biologics Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 3.37 Bn -20.49 50.98 3.37 Bn
54 DYN Dyne Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 3.18 Bn -6.15 — 3.18 Bn
55 ARQT Arcutis Biotherapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 3.11 Bn 109.08 6.70 2.87 Bn
56 CLDX Celldex Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 3.02 Bn -9.83 19,122.53 3.02 Bn
57 MBX MBX Biosciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 2.99 Bn -28.68 — 2.99 Bn
58 IMNM Immunome Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 2.96 Bn -10.96 593.06 2.44 Bn
59 IRON Disc Medicine, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 2.95 Bn -14.67 — 2.95 Bn
60 NRIX Nurix Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 2.93 Bn -8.57 79.61 2.48 Bn
61 ZLAB Zai Lab Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 2.80 Bn -14.90 6.24 2.10 Bn
62 SLS SELLAS Life Sciences Group, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 2.64 Bn -81.36 — 2.64 Bn
63 OCUL Ocular Therapeutix, Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 2.58 Bn -8.52 49.52 2.58 Bn
64 VERA Vera Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 2.44 Bn -6.10 — 2.44 Bn
65 NKTR Nektar Therapeutics primary H-02 Pharmaceuticals and Biotechnology HG-01 2.41 Bn -20.29 44.17 1.73 Bn
66 VRDN Viridian Therapeutics, Inc.\DE primary H-02 Pharmaceuticals and Biotechnology HG-01 2.40 Bn -5.99 33.69 2.40 Bn
67 XTLB Xtl Biopharmaceuticals Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 2.29 Bn -2,975.41 — 2.29 Bn
68 BCRX Biocryst Pharmaceuticals Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 2.29 Bn -5.95 4.28 1.94 Bn
69 URGN UroGen Pharma Ltd. primary H-02 Pharmaceuticals and Biotechnology HG-01 2.27 Bn -36.49 12.04 2.16 Bn
70 BHVN Biohaven Ltd. primary H-02 Pharmaceuticals and Biotechnology HG-01 2.27 Bn -3.87 — 2.00 Bn
71 PHVS Pharvaris N.V. primary H-02 Pharmaceuticals and Biotechnology HG-01 2.23 Bn -11.24 — 1.86 Bn
72 ADMA Adma Biologics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 2.15 Bn 12.91 4.19 2.01 Bn
73 GMAB Genmab A/S primary H-02 Pharmaceuticals and Biotechnology HG-01 2.14 Bn 0.17 0.34 0.63 Bn
74 KOD Kodiak Sciences Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 2.12 Bn -8.78 — 2.12 Bn
75 AGIO Agios Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 2.06 Bn -5.01 20.99 2.06 Bn
76 RAPP Rapport Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 2.06 Bn -15.00 102.87 2.06 Bn
77 CMPS COMPASS Pathways plc primary H-02 Pharmaceuticals and Biotechnology HG-01 2.04 Bn -5.16 — 2.04 Bn
78 ZBIO Zenas BioPharma, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 2.03 Bn -4.89 2,033.16 2.03 Bn
79 ZYME Zymeworks Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.98 Bn -13.21 53.36 1.71 Bn
80 STOK Stoke Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.98 Bn -9.53 71.80 1.69 Bn
81 XNCR Xencor Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 1.89 Bn -11.60 18.04 1.52 Bn
82 VIR Vir Biotechnology, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.82 Bn -7.23 6.00 1.82 Bn
83 SNDX Syndax Pharmaceuticals Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 1.77 Bn -9.74 7.00 1.22 Bn
84 INBX Inhibrx Biosciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.76 Bn -13.23 1,357.12 1.76 Bn
85 IMCR Immunocore Holdings plc primary H-02 Pharmaceuticals and Biotechnology HG-01 1.75 Bn -96.63 4.06 0.87 Bn
86 GLPGF Lakefront Biotherapeutics NV primary H-02 Pharmaceuticals and Biotechnology HG-01 1.73 Bn 0.00 1.50 1.73 Bn
87 RXRX Recursion Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.72 Bn -3.31 31.30 1.17 Bn
88 SEPN Septerna, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.71 Bn -122.77 17.33 1.71 Bn
89 GHRS GH Research PLC primary H-02 Pharmaceuticals and Biotechnology HG-01 1.68 Bn -26.90 — 1.31 Bn
90 DMRA Damora Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.63 Bn -6.19 — 1.09 Bn
91 NVAX Novavax Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 1.63 Bn -6.57 3.93 0.91 Bn
92 SCNI Scinai Immunotherapeutics Ltd. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.63 Bn -194.01 943.71 1.62 Bn
93 ANAB Anaptysbio, Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 1.60 Bn -67.19 8.06 1.32 Bn
94 BCAX Bicara Therapeutics Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.60 Bn -8.63 — 1.60 Bn
95 ATAI AtaiBeckley Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.59 Bn -10.33 523.75 1.59 Bn
96 FBRX Forte Biosciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.58 Bn -20.71 — 1.23 Bn
97 AAPG Ascentage Pharma Group International primary H-02 Pharmaceuticals and Biotechnology HG-01 1.54 Bn -9.11 20.12 1.26 Bn
98 RARE Ultragenyx Pharmaceutical Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.47 Bn -3.17 2.04 1.17 Bn
99 ANRO Alto Neuroscience, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.46 Bn -17.48 — 1.46 Bn
100 MAZE Maze Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.45 Bn -13.63 72.27 1.45 Bn
101 GLUE Monte Rosa Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.44 Bn -9.37 50.20 0.81 Bn
102 TYRA Tyra Biosciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.43 Bn -9.65 — 1.43 Bn
103 AVBP ArriVent BioPharma, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.42 Bn -8.67 — 1.42 Bn
104 REPL Replimune Group, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.40 Bn -4.73 — 1.40 Bn
105 OMER Omeros Corp primary H-02 Pharmaceuticals and Biotechnology HG-01 1.40 Bn 82.16 36.50 1.40 Bn
106 SVRA Savara Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 1.37 Bn -9.82 — 1.37 Bn
107 ABSI Absci Corp primary H-02 Pharmaceuticals and Biotechnology HG-01 1.37 Bn -11.30 876.13 1.17 Bn
108 ORIC Oric Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.36 Bn -8.64 — 1.36 Bn
109 CGEM Cullinan Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.33 Bn -6.49 — 1.33 Bn
110 VOR Vor Biopharma Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.27 Bn -1.37 — 1.27 Bn
111 ALMS Alumis Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.25 Bn -5.18 150.67 0.75 Bn
112 CRVS Corvus Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.23 Bn -25.77 — 1.02 Bn
113 MNKD Mannkind Corp primary H-02 Pharmaceuticals and Biotechnology HG-01 1.22 Bn -28.00 3.10 1.11 Bn
114 JANX Janux Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.22 Bn -11.87 50.76 1.22 Bn
115 JBIO Jade Biosciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.16 Bn -7.56 — 1.16 Bn
116 CLYM Climb Bio, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.14 Bn -19.84 — 1.14 Bn
117 ABUS Arbutus Biopharma Corp primary H-02 Pharmaceuticals and Biotechnology HG-01 1.02 Bn 6.67 5.60 0.92 Bn
118 MLTX MoonLake Immunotherapeutics primary H-02 Pharmaceuticals and Biotechnology HG-01 1.01 Bn -3.82 — 0.48 Bn
119 OKYO OKYO Pharma Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 0.99 Bn -118.02 — 0.99 Bn
120 WVE Wave Life Sciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.97 Bn -4.81 14.90 0.61 Bn
121 MNPR Monopar Therapeutics primary H-02 Pharmaceuticals and Biotechnology HG-01 0.97 Bn -70.03 — 0.92 Bn
122 ARDX Ardelyx, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.95 Bn -17.06 2.11 0.67 Bn
123 GERN Geron Corp primary H-02 Pharmaceuticals and Biotechnology HG-01 0.94 Bn -13.99 3.86 0.64 Bn
124 TBPH Theravance Biopharma, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.88 Bn 20.84 8.45 0.49 Bn
125 RIGL Rigel Pharmaceuticals Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.88 Bn 2.72 3.17 0.78 Bn
126 ANNX Annexon, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.87 Bn -4.26 — 0.87 Bn
127 STTK Shattuck Labs, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.82 Bn -15.12 816.31 0.82 Bn
128 AVTX Avalo Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.80 Bn -7.93 — 0.80 Bn
129 ACRS Aclaris Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.79 Bn -9.89 95.78 0.79 Bn
130 CTMX CytomX Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.77 Bn -10.21 42.29 0.44 Bn
131 PHAR Pharming Group N.V. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.76 Bn -122.18 2.28 0.60 Bn
132 ZURA Zura Bio Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 0.72 Bn -6.21 — 0.72 Bn
133 AURA Aura Biosciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.68 Bn -6.22 — 0.61 Bn
134 IRWD Ironwood Pharmaceuticals Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.67 Bn 3.03 1.72 0.59 Bn
135 SLN Silence Therapeutics plc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.64 Bn -16.42 1,038.05 0.57 Bn
136 ASMB Assembly Biosciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.63 Bn 502.49 8.35 0.30 Bn
137 ALT Altimmune, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.62 Bn -8.43 — 0.62 Bn
138 CBIO Crescent Biopharma, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.61 Bn -3.75 589.05 0.44 Bn
139 OCS Oculis Holding AG primary H-02 Pharmaceuticals and Biotechnology HG-01 0.60 Bn -340,055.90 — 0.60 Bn
140 TECX Tectonic Therapeutic, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.58 Bn -6.72 — 0.58 Bn
141 VALN Valneva SE primary H-02 Pharmaceuticals and Biotechnology HG-01 0.57 Bn -9.79 3.43 0.43 Bn
142 SGMT Sagimet Biosciences Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.57 Bn -11.82 — 0.57 Bn
143 ARVN Arvinas, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.57 Bn 61.21 1.80 0.00 Bn
144 CTNM Contineum Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.57 Bn -9.40 — 0.57 Bn
145 BBOT BridgeBio Oncology Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.54 Bn -2.72 — 0.32 Bn
146 OABI OmniAb, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.52 Bn -11.67 13.43 0.46 Bn
147 IMUX Immunic, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.52 Bn -4.48 — 0.52 Bn
148 PRLD Prelude Therapeutics Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.50 Bn -7.41 22.27 0.22 Bn
149 PRTA Prothena Corp Public Ltd Co primary H-02 Pharmaceuticals and Biotechnology HG-01 0.48 Bn -11.04 8.89 0.20 Bn
150 KMDA Kamada Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 0.47 Bn 15.22 2.47 0.40 Bn
151 NEUP Neuphoria Therapeutics Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.47 Bn -19.72 — 0.45 Bn
152 ANL Adlai Nortye Ltd. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.47 Bn -10.27 78.36 0.23 Bn
153 RLMD Relmada Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.46 Bn -7.55 — 0.46 Bn
154 PBYI Puma Biotechnology, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.46 Bn 15.39 1.99 0.37 Bn
155 DRUG Bright Minds Biosciences Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.45 Bn -15.52 — 0.45 Bn
156 CCCC C4 Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.45 Bn -4.44 12.85 0.20 Bn
157 AVIR Atea Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.42 Bn -3.09 — 0.42 Bn
158 RZLT Rezolute, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.42 Bn -5.18 — 0.42 Bn
159 ARCT Arcturus Therapeutics Holdings Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.42 Bn -4.40 14.27 0.23 Bn
160 CMPX Compass Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.41 Bn -5.07 — 0.41 Bn
161 BIOA BioAge Labs, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.41 Bn -4.36 39.58 0.41 Bn
162 LRMR Larimar Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.40 Bn -2.28 — 0.24 Bn
163 EVMN Evommune, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.39 Bn -4.14 39.23 0.19 Bn
164 ENTA Enanta Pharmaceuticals Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.38 Bn -6.09 5.89 0.19 Bn
165 HMDCF HUTCHMED (China) Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 0.38 Bn — — 0.39 Bn
166 EYPT EyePoint, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.37 Bn -1.21 134.36 0.19 Bn
167 CATX Perspective Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.36 Bn -3.02 — 0.36 Bn
168 WHWK Whitehawk Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.35 Bn -4.36 — 0.35 Bn
169 FHTX Foghorn Therapeutics Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.33 Bn -5.03 9.00 0.26 Bn
170 UPB Upstream Bio, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.32 Bn -2.03 102.81 0.32 Bn
171 ELDN Eledon Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.32 Bn -3.86 — 0.32 Bn
172 EPRX Eupraxia Pharmaceuticals Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.32 Bn -6.37 — 0.32 Bn
173 STRO Sutro Biopharma, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.31 Bn -2.69 3.39 0.14 Bn
174 TRDA Entrada Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.30 Bn -1.82 64.42 0.30 Bn
175 AGEN Agenus Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.28 Bn 3.08 2.13 0.28 Bn
176 EQ Equillium, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.28 Bn -15.70 — 0.28 Bn
177 BCYC Bicycle Therapeutics Plc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.28 Bn -1.46 4.56 0.28 Bn
178 ACIU AC Immune SA primary H-02 Pharmaceuticals and Biotechnology HG-01 0.28 Bn -5.13 12.56 0.28 Bn
179 SABS SAB Biotherapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.28 Bn -4.04 — 0.28 Bn
180 GALT Galectin Therapeutics Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.27 Bn -9.52 — 0.27 Bn
181 MGNX Macrogenics Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.26 Bn -16.20 1.56 0.15 Bn
182 ANTX AN2 Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.26 Bn -7.05 — 0.26 Bn
183 FIXX Q32 Bio Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.26 Bn 63.96 — 0.15 Bn
184 AVXL Anavex Life Sciences Corp. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.26 Bn -18.19 — 0.14 Bn
185 IVVD Invivyd, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.25 Bn -3.01 4.50 0.09 Bn
186 ALXO Alx Oncology Holdings Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.25 Bn -3.12 — 0.25 Bn
187 CAMP Camp4 Therapeutics Corp primary H-02 Pharmaceuticals and Biotechnology HG-01 0.25 Bn -5.05 59.91 0.25 Bn
188 ALEC Alector, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.25 Bn -2.87 18.17 0.08 Bn
189 CYDY CytoDyn Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.25 Bn -7.46 — 0.25 Bn
190 SRZN Surrozen, Inc./DE primary H-02 Pharmaceuticals and Biotechnology HG-01 0.23 Bn -3.80 20.14 0.23 Bn
191 CGEN Compugen Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 0.23 Bn 6.54 3.11 0.14 Bn
192 KRRO Korro Bio, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.23 Bn -2.77 96.15 0.11 Bn
193 KROS Keros Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.22 Bn -2.49 6.84 -0.03 Bn
194 NMRA Neumora Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.22 Bn -1.36 — 0.22 Bn
195 PYXS Pyxis Oncology, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.22 Bn -3.34 15.92 0.19 Bn
196 GLSI Greenwich LifeSciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.22 Bn -9.88 — 0.22 Bn
197 PEPG PepGen Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.22 Bn -3.02 — 0.22 Bn
198 PLX Protalix BioTherapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.21 Bn 10.07 2.64 0.17 Bn
199 PRQR ProQR Therapeutics N.V. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.21 Bn -4.28 9.83 0.07 Bn
200 ABOS Acumen Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.21 Bn -1.98 — 0.21 Bn
201 FTH Faeth Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.21 Bn -1.05 — 0.21 Bn
202 CHRS Coherus Oncology, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.20 Bn -1.55 4.01 0.10 Bn
203 ARMP Armata Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.20 Bn -3.27 — 0.18 Bn
204 ORMP Oramed Pharmaceuticals Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.20 Bn 1.15 — 0.20 Bn
205 CUE Cue Biopharma, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.19 Bn -1.92 8.65 0.18 Bn
206 ADAG Adagene Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.19 Bn -13.14 32.66 0.19 Bn
207 ADCT ADC Therapeutics SA primary H-02 Pharmaceuticals and Biotechnology HG-01 0.19 Bn -1.28 2.50 -0.03 Bn
208 NBP NovaBridge Biosciences primary H-02 Pharmaceuticals and Biotechnology HG-01 0.19 Bn -2.47 — 0.19 Bn
209 QNCX Quince Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.18 Bn -2.43 — 0.18 Bn
210 IPHA Innate Pharma SA primary H-02 Pharmaceuticals and Biotechnology HG-01 0.18 Bn -1.11 60.09 0.18 Bn
211 MOLN Molecular Partners Ag primary H-02 Pharmaceuticals and Biotechnology HG-01 0.18 Bn -2.51 214.11 0.18 Bn
212 XLO Xilio Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.17 Bn -5.57 2.72 0.04 Bn
213 OKUR OnKure Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.17 Bn -2.71 — -0.01 Bn
214 RANI Rani Therapeutics Holdings, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.16 Bn -4.82 32.48 0.16 Bn
215 MDWD MediWound Ltd. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.16 Bn -5.08 13.30 0.12 Bn
216 NGEN Nervgen Pharma Corp. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.16 Bn -116.03 — 0.16 Bn
217 MIST Milestone Pharmaceuticals Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.15 Bn — — -0.02 Bn
218 MSLE Satellos Bioscience Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.15 Bn -2.84 — 0.15 Bn
219 ENTX Entera Bio Ltd. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.15 Bn -10.09 — 0.13 Bn
220 IFRX InflaRx N.V. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.14 Bn 0.00 1,788.24 -0.04 Bn
221 UNCY Unicycive Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.14 Bn -4.99 — 0.14 Bn
222 SPRB Spruce Biosciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.14 Bn -2.80 — 0.14 Bn
223 INDP Indaptus Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.13 Bn -8.95 — 0.12 Bn
224 IBIO iBio, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.13 Bn -3.99 1,316.36 0.13 Bn
225 PMN ProMIS Neurosciences Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.13 Bn -3.08 — 0.08 Bn
226 HURA TuHURA Biosciences, Inc./NV primary H-02 Pharmaceuticals and Biotechnology HG-01 0.13 Bn -4.18 — 0.13 Bn
227 CNTB Connect Biopharma Holdings Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 0.13 Bn -1.85 43.23 0.13 Bn
228 NRXP NRX Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.13 Bn -5.99 36.76 0.10 Bn
229 BDTX Black Diamond Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.12 Bn -2.52 — 0.01 Bn
230 RFL Rafael Holdings, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.12 Bn -4.41 119.97 0.12 Bn
231 TLSA Tiziana Life Sciences Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 0.11 Bn -6.55 — 0.11 Bn
232 GNLX GENELUX Corp primary H-02 Pharmaceuticals and Biotechnology HG-01 0.11 Bn -3.31 — 0.11 Bn
233 CRBP Corbus Pharmaceuticals Holdings, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.11 Bn — — -0.05 Bn
234 INO Inovio Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.11 Bn -1.40 — 0.11 Bn
235 COYA Coya Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.11 Bn -4.86 13.51 0.07 Bn
236 CTOR Citius Oncology, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.10 Bn -2.20 60.89 0.10 Bn
237 PLYX Polaryx Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.10 Bn -10.06 — 0.09 Bn
238 ONCY Oncolytics Biotech Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.10 Bn -3.15 — 0.10 Bn
239 RLYB Rallybio Corp primary H-02 Pharmaceuticals and Biotechnology HG-01 0.10 Bn 2.09 147.33 0.10 Bn
240 ALDX Aldeyra Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.09 Bn -3.92 — 0.09 Bn
241 OTLK Outlook Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.09 Bn -1.44 — 0.08 Bn
242 KZIA Kazia Therapeutics Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 0.09 Bn — — 0.09 Bn
243 RVRC Revium Rx. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.09 Bn -118.64 — 0.09 Bn
244 PYPD PolyPid Ltd. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.09 Bn 2.72 — 0.08 Bn
245 ACRV Acrivon Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.08 Bn -1.15 — 0.08 Bn
246 FBIO Fortress Biotech, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.08 Bn 10.01 1.21 -0.11 Bn
247 KLRS Kalaris Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.08 Bn -1.73 — 0.08 Bn
248 MAIA MAIA Biotechnology, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.08 Bn -3.01 — 0.05 Bn
249 ATHE Alterity Therapeutics Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 0.08 Bn 0.00 — 0.08 Bn
250 GANX Gain Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.07 Bn -4.04 — 0.07 Bn
251 TELO Telomir Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.07 Bn -1.48 — 0.07 Bn
252 CRDF Cardiff Oncology, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.07 Bn -1.72 121.56 0.07 Bn
253 SPRO Spero Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.07 Bn 11.71 1.44 0.02 Bn
254 XBIT XBiotech Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.07 Bn -1.60 — 0.07 Bn
255 DWTX Dogwood Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.07 Bn -1.83 — 0.07 Bn
256 HRTX Heron Therapeutics, Inc. /De/ primary H-02 Pharmaceuticals and Biotechnology HG-01 0.06 Bn -7.08 0.42 0.02 Bn
257 SCYX Scynexis Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.06 Bn -3.24 3.04 -0.06 Bn
258 ALGS Aligos Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.06 Bn -0.80 15.13 0.03 Bn
259 RNTX Rein Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.06 Bn -1.12 — 0.06 Bn
260 IBO Impact Biomedical Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.05 Bn -2.82 1,515.04 0.05 Bn
261 BDRX Biodexa Pharmaceuticals Plc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.05 Bn -6.38 — 0.04 Bn
262 MCRB Seres Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.05 Bn -0.63 27.58 0.05 Bn
263 IMMP IMMUTEP Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 0.05 Bn -0.43 5.09 0.05 Bn
264 NMAD Nomad Power Solutions, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.05 Bn -7.57 — 0.05 Bn
265 TIL Instil Bio, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.05 Bn -1.27 — 0.05 Bn
266 ALP Alpha Compute Corp primary H-02 Pharmaceuticals and Biotechnology HG-01 0.05 Bn -0.02 0.19 0.05 Bn
267 PTN Palatin Technologies Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.05 Bn -7.87 3.83 0.05 Bn
268 HOWL Werewolf Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.05 Bn -1.38 2.23 0.05 Bn
269 ATYR aTYR PHARMA INC primary H-02 Pharmaceuticals and Biotechnology HG-01 0.04 Bn -0.70 294.15 -0.01 Bn
270 EDSA Edesa Biotech, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.04 Bn -4.47 — 0.04 Bn
271 IMA ImageneBio, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.04 Bn — — -0.09 Bn
272 NXTC NextCure, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.04 Bn -0.98 — 0.04 Bn
273 ELTX Elicio Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.04 Bn -1.09 — 0.02 Bn
274 SER Serina Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.04 Bn -1.45 315.10 0.02 Bn
275 ATNM Actinium Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.04 Bn 3.44 1.11 0.04 Bn
276 MREO Mereo BioPharma Group plc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.04 Bn -1.01 77.62 0.04 Bn
277 FLNA Filana Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.04 Bn -1.58 — 0.04 Bn
278 LITS Lite Strategy, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.04 Bn -0.65 — 0.03 Bn
279 APLM Apollomics Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.04 Bn -3.72 4.79 0.03 Bn
280 CNTX Context Therapeutics Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.04 Bn -0.77 — 0.04 Bn
281 BHST Bioharvest Sciences Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn -3.16 0.95 0.02 Bn
282 BETRF BetterLife Pharma Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn -21.82 — 0.04 Bn
283 KYNB Kyntra Bio, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn 0.17 4.29 0.03 Bn
284 KAPA Kairos Pharma, LTD. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn -6.19 0.38 0.03 Bn
285 BRNS Barinthus Biotherapeutics plc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn -0.74 — 0.03 Bn
286 TAOX TAO Synergies Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn -1.40 39.85 0.03 Bn
287 YDESW YD Bio Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn — — 0.03 Bn
288 CLRB Cellectar Biosciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn -1.24 — 0.03 Bn
289 RAPH Raphael Pharmaceutical Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn -23.02 — 0.03 Bn
290 IGC IGC Pharma, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn -12.26 93.50 0.03 Bn
291 ADIL Adial Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn -0.43 — 0.03 Bn
292 ABVC Abvc Biopharma, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn -3.57 — 0.03 Bn
293 RDPTF Radiopharm Theranostics Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 0.02 Bn -0.28 97.58 0.02 Bn
294 VRXA Veraxa Biotech AG - Post de-SPAC primary H-02 Pharmaceuticals and Biotechnology HG-01 0.02 Bn -0.30 869.19 0.02 Bn
295 NNVC Nanoviricides, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.02 Bn -2.80 — 0.02 Bn
296 LTRN Lantern Pharma Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.02 Bn -1.47 — 0.02 Bn
297 EVAX Evaxion A/S primary H-02 Pharmaceuticals and Biotechnology HG-01 0.02 Bn -2.44 2.82 0.01 Bn
298 GRDX GridAI Technologies Corp. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.02 Bn -1.11 261.63 0.02 Bn
299 JSPR Jasper Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.02 Bn -0.10 — 0.02 Bn
300 DYAI Dyadic International Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.02 Bn -2.59 4.86 0.01 Bn